Career history of Michael S. Ostrach
Former positions of Michael S. Ostrach
Companies | Position | Start | End |
---|---|---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Director of Finance/CFO | 2015-02-28 | 2021-02-28 |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Chief Operating Officer | 2005-09-11 | 2006-10-26 |
Director of Finance/CFO | 2005-09-11 | 2006-10-26 | |
General Counsel | 2005-09-11 | 2006-10-26 | |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Chief Operating Officer | 1997-09-30 | 2003-12-31 |
President | 1997-09-30 | 2003-12-31 | |
Cetus Corp. | General Counsel | 1980-12-31 | 1990-12-31 |
Chiron Technologies, Inc.
Chiron Technologies, Inc. Computer Processing HardwareElectronic Technology Chiron Technologies, Inc. focuses on electronic computers. The company is headquartered in Colts Neck, NJ. | President | - | - |
Training of Michael S. Ostrach
Brown University | Undergraduate Degree |
Stanford Law School | Graduate Degree |
Statistics
International
United States | 8 |
Operational
Chief Operating Officer | 2 |
President | 2 |
Director of Finance/CFO | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
Private companies | 4 |
---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
Chiron Technologies, Inc.
Chiron Technologies, Inc. Computer Processing HardwareElectronic Technology Chiron Technologies, Inc. focuses on electronic computers. The company is headquartered in Colts Neck, NJ. | Electronic Technology |
Cetus Corp. | Health Technology |
- Stock Market
- Insiders
- Michael S. Ostrach
- Experience